KPW
GBT

Kore Private Wealth’s Global Blood Therapeutics, Inc. GBT Stock Holding History

Kore Private Wealth’s Portfolio GBT Stock Details GBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-1,000
Closed -$63K – 1166
2020
Q2 		$63K Hold
1,000
– – 0.01% 416
2020
Q1 		$51K Hold
1,000
– – 0.01% 410
2019
Q4 		$79K Buy
+1,000
New +$59.3K 0.02% 409
2019
Q2 		– Sell
-1,000
Closed -$53K – 834
2019
Q1 		$53K Hold
1,000
– – 0.01% 376
2018
Q4 		$41K Buy
+1,000
New +$37.5K 0.01% 406

Other funds holding GBT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Kore Private Wealth's GBT Position: Q3 2020 in Review

Kore Private Wealth sold out of Global Blood Therapeutics, Inc. (GBT) in Q3 2020, closing a stake of 1,000 shares — an estimated $63K sold.

Kore Private Wealth first reported a position in GBT in Q4 2018 and held it in 5 quarters. The position peaked at $79K in Q4 2019. 229 funds tracked by Wall St. Rank hold GBT as of Q3 2020.

  • Kore Private Wealth reported no remaining Global Blood Therapeutics, Inc. position as of Q3 2020 after selling out during the quarter.
  • Kore Private Wealth sold 1,000 Global Blood Therapeutics, Inc. shares in Q3 2020, an estimated $63K.
  • Kore Private Wealth first reported a position in Global Blood Therapeutics, Inc. in Q4 2018 and held it in 5 quarters.
  • Kore Private Wealth's Global Blood Therapeutics, Inc. position peaked at $79K in Q4 2019.
  • 229 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q3 2020.

Based on Kore Private Wealth's 13F filing for Q3 2020, filed 13 Nov 2020.